Cancer vaccines protect against kidney disease return
A vaccine to protect patients with kidney cancer again. About 50% of patients with kidney cancer, replaced again within five years. Current treatment is to remove all or part of the kidney. Scientists at the University of Lubeck, Germany, said that survival rates of patients are much higher if the vaccine. The study published in the journal The Lancet. Kidney cancer accounts for about 5,900 deaths annually in the United Kingdom. In this study, 379 patients with kidney cancer in Germany.They all had their kidneys removed part or all of the kidney.After surgery, one group was given no further treatment. The other group received a six vaccines at intervals of four weeks. 77% of patients who had survived the vaccine beyond five years. The other group, 68% survived. The side
effects were mild to moderate only affected 12 patients. Patients with tumors (cancers) are larger than 2.5 cm can now be considered for this treatment, said Professor Dieter Jocham (principal investigator). He said that we are light years away from having a vaccine that can occur on a large scale.Because the vaccine is used in parts of cancer patients, the bodys immune system, each of these patients should be trimmed. In this technique, cells are removed from the tumor. Then killed himself to avoid the formation of tumors. You will be connected to a foreign body, such as a tuberculosis bacterium. Then injected back into the patients body. This allowed to know the patients immune system and attack cancer cells in the tumor and not backward.
Although kidney cancer israre (only 3% of cancers), its incidence is growing rapidly. Experts say this method is important and encouraging.